A PMA, or Premarket Approval, is the most rigorous review process the FDA uses to evaluate medical devices before they can be sold in the United States. It applies specifically to Class III medical devices, the highest-risk category, which includes things like pacemakers, artificial hearts, and implantable defibrillators. If a device supports or sustains human life, plays a major role in preventing serious health problems, or poses an unreasonable risk of illness or injury, it almost certainly needs a PMA before reaching patients.
Why Some Devices Need a PMA
The FDA groups all medical devices into three classes based on risk. Class I covers low-risk items like tongue depressors and bandages. Class II includes moderate-risk devices like powered wheelchairs and pregnancy tests. Class III is reserved for the highest-risk devices, and this is where PMA comes in.
The logic is straightforward: the more a device could harm you, the more evidence the FDA demands before allowing it on the market. For Class III devices, general safety controls and comparisons to existing products aren’t enough. The manufacturer must independently prove, through clinical data, that the device is both safe and effective for its intended use. This makes PMA the most stringent type of device review the FDA conducts.
How PMA Differs From 510(k) Clearance
Most medical devices reach the market through a faster pathway called a 510(k), which requires manufacturers to show their device is “substantially equivalent” to one already legally sold. That means it has the same intended use and either identical technology or different technology that doesn’t raise new safety concerns. The 510(k) process is essentially a comparison exercise.
PMA is fundamentally different. Instead of comparing a new device to an existing one, the manufacturer must build an independent case from scratch. This includes original clinical trial data from human subjects, nonclinical laboratory testing, and a detailed description of how the device is manufactured. The FDA reviews all of this evidence before making an approval decision. A device that fails to demonstrate substantial equivalence through the 510(k) pathway may be required to pursue PMA instead.
What Goes Into a PMA Application
A PMA submission is extensive. It requires separate sections covering nonclinical laboratory studies and clinical investigations involving human subjects. The clinical section alone must include details on how patients were selected, the demographics of the study population, the study period, safety and effectiveness data, adverse reactions, device failures, and statistical analyses of the results. If any patient died during a clinical trial or didn’t complete it, the FDA expects individual case reports.
Beyond clinical evidence, the application must describe how the device works, the scientific principles behind it, and its key physical and performance characteristics. Manufacturers also need to document their manufacturing process in enough detail that an expert in quality control could evaluate whether the device is being made reliably and safely. Labeling, packaging, and storage procedures are all part of the filing as well.
The depth of documentation reflects the stakes involved. These are devices that go inside people’s bodies, keep their hearts beating, or replace critical biological functions. The FDA wants to see comprehensive proof before giving the green light.
How Long the Review Takes
The FDA’s target for reviewing a PMA application is 180 days when no advisory committee input is needed. When the agency convenes an outside panel of experts to weigh in, the target extends to 320 days. These are “FDA days,” meaning the clock pauses when the agency sends questions back to the manufacturer and restarts when the company responds. In practice, the total calendar time from submission to approval often runs longer than those targets suggest, because the back-and-forth between the FDA and the manufacturer can add months.
Under current performance goals, the FDA aims to meet the 180-day timeline for 90% of applications when submission volumes stay below certain thresholds. Higher volumes can lower that target to 75% or 80%.
What Happens After Approval
Getting a PMA approval isn’t the end of the process. The FDA treats it as an ongoing relationship with the manufacturer. Continued approval depends on submitting annual reports that cover any changes to the device, new clinical data, relevant scientific literature, and a bibliography of unpublished studies involving the device or similar products.
Manufacturers must also comply with Medical Device Reporting requirements, which means promptly reporting any deaths or serious injuries the device may have caused or contributed to. They’re required to maintain files on all adverse events and submit summary reports each year. In some cases, the FDA makes post-approval studies a condition of the original approval, requiring manufacturers to continue tracking a specific number of patients and reporting on the device’s long-term safety, effectiveness, and reliability.
Any significant modification to an approved device, whether it involves the design, materials, manufacturing process, or intended use, typically requires a PMA supplement. This is a separate submission that goes through its own FDA review before the change can be implemented. Unlike lower-risk devices where manufacturers have more flexibility to make changes independently, PMA-approved devices are held to a tighter standard at every stage of their lifecycle.
Examples of Devices Requiring PMA
Class III devices span a wide range of medical specialties, but they share one thing in common: the consequences of failure are serious. Implantable cardiac defibrillators, heart valves, cochlear implants, and implantable insulin pumps all fall into this category. So do some high-risk diagnostic tests, certain types of breast implants, and deep brain stimulation systems used to treat conditions like Parkinson’s disease.
If you’ve had a major medical device implanted or are considering a procedure that involves one, there’s a good chance that device went through the PMA process. You can search the FDA’s publicly available PMA database to find approval details, clinical summaries, and any conditions the FDA placed on the approval for a specific device.